Formulation and release kinetics of cephalexin monohydrate from biodegradable polymeric microspheres
- 1 January 1996
- journal article
- Published by Taylor & Francis in Journal of Microencapsulation
- Vol. 13 (2) , 195-205
- https://doi.org/10.3109/02652049609052907
Abstract
Sustained release cephalexin microspheres have been formulated with poly(L-lactic acid) for intraperitoneal administration. Microspheres were prepared with spray-dried cephalexin by phase separation in organic solvent containing a fixed concentration of polymer, then sieve-sized. Batch-to-batch reproducibility of microsphere size distribution and encapsulation efficiency (>95%) were demonstrated. The quality of the microspheres was dependent on the rate of stirring during preparation and was highest as 400 rpm. Scanning electron micrographs revealed approximately spherical shapes and porous surfaces. The release of cephalexin followed second order dissolution model kinetics for multiparticulate systems. The apparent second order rate constant, k2, was lowest for the highest sieve-size fraction (250–425 μm) and varied with drug loading reaching a minimum at 33% w/w. A lower molecular weight PLA of 50 000 produced a faster release of cephalexin from microspheres. Cephalexin was released from microspheres for at least 4 h compared to only 10 min for complete dissolution of an equivalent weight of cephalexin powder, indicating sustained release which may be appropriate in treating localized infections.Keywords
This publication has 11 references indexed in Scilit:
- Intraperitoneal ciprofloxacin for the treatment of peritonitis in patients receiving continuous ambulatory peritoneal dialysis (CAPD)Journal of Antimicrobial Chemotherapy, 1990
- Oral ciprofloxacin in the treatment of peritonitis in patients on continuous ambulatory peritoneal dialysisJournal of Antimicrobial Chemotherapy, 1990
- Microencapsulation using poly(DL-lactic acid) I: Effect of preparative variables on the microcapsule characteristics and release kineticsJournal of Microencapsulation, 1990
- The effect of the addition of low molecular weight poly(dl-lactide) on drug release from biodegradable poly(dl-lactide) drug delivery systemsInternational Journal of Pharmaceutics, 1989
- Poly(lactic acid) microencapsulated oxytetracycline:in vitroandin vivoevaluationJournal of Microencapsulation, 1984
- Use of organ cultures to evaluate biodegradation of polymer implant materialsJournal of Biomedical Materials Research, 1973
- Resorption rate, route of elimination, and ultrastructure of the implant site of polylactic acid in the abdominal wall of the ratJournal of Biomedical Materials Research, 1973
- Biodegradable poly(lactic acid) polymersJournal of Biomedical Materials Research, 1971
- MicroencapsulationJournal of Pharmaceutical Sciences, 1970
- Spray-Congealed Formulations of Sulfaethidole (SETD) and Waxes for Prolonged-Release MedicationJournal of Pharmaceutical Sciences, 1968